Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Daria Handkiewicz-Junak
CONTACT
Agnieszka Ciomber
CONTACT
Lead
Maria Sklodowska-Curie National Research Institute of Oncology
The intervention will consist of a single administration of 177Lu-PSMA in the research arm. Both the study and control groups will receive standard hormone therapy. The study population includes 200 adult men with high-risk or very high-risk prostate cancer, with no signs of cancer dissemination in radiological examinations after completion of radiotherapy and continued hormone therapy Participation time in the Study: intervention phase - 1 day; observation phase - 5 years
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted